A Subsequent New Drug License (SNDL) is a regulatory approval granted for modifications or variations in an existing drug, such as a new dosage form, strength, or route of administration. It ensures safety, efficacy, and quality standards while allowing for advancements and diversification within pharmaceutical offerings.
Issues with this site? Let us know.